Mediators of allostasis and systemic toxicity in bipolar disorder.
about
Oxidative Stress Implications in the Affective Disorders: Main Biomarkers, Animal Models Relevance, Genetic Perspectives, and Antioxidant ApproachesStaging Models in Bipolar Disorder: A Systematic Review of the LiteratureThe Neurobiology of Bipolar Disorder: An Integrated ApproachAllostasis as a conceptual framework linking bipolar disorder and addictionNeurobiological underpinnings of bipolar disorder focusing on findings of diffusion tensor imaging: a systematic reviewThe relationship between interleukin-1 receptor antagonist and cognitive function in older adults with bipolar disorder.Integrated neurobiology of bipolar disorder.A preliminary investigation on the efficacy of N-acetyl cysteine for mania or hypomania."Is bipolar disorder an endocrine condition?" Glucose abnormalities in bipolar disorder.Disturbances in Hypothalamic-Pituitary-Adrenal Axis and Immunological Activity Differentiating between Unipolar and Bipolar Depressive EpisodesCumulative stress pathophysiology in schizophrenia as indexed by allostatic loadChildhood trauma in bipolar disorder.Challenges and developments in research of the early stages of bipolar disorder.Abnormal glycemic homeostasis at the onset of serious mental illnesses: A common pathwayAge as a predictor of cognitive decline in bipolar disorder.Stress, Inflammation, and Cellular Vulnerability during Early Stages of Affective Disorders: Biomarker Strategies and Opportunities for Prevention and Intervention.Neurotrophins, inflammation and oxidative stress as illness activity biomarkers in bipolar disorder.On the role of the extracellular space on the holistic behavior of the brain.Update on bipolar disorder biomarker candidates.The Misfortunes of Moral Enhancement.Biological hypotheses and biomarkers of bipolar disorder.Impaired endoplasmic reticulum stress response in bipolar disorder: cellular evidence of illness progression.Val66Met polymorphism and serum brain-derived neurotrophic factor in bipolar disorder: an open-label trial.Cumulative morbidity and prognostic staging of illness in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD).Abnormal levels of vascular endothelial biomarkers in schizophrenia.Allostatic load but not medical burden predicts memory performance in late-life bipolar disorder.Shortened telomere length in bipolar disorder: a comparison of the early and late stages of disease.Lithium modulates the production of peripheral and cerebral cytokines in an animal model of mania induced by dextroamphetamine.Oxidative stress markers, cognitive functions, and psychosocial functioning in bipolar disorder: an empirical cross-sectional study.The effect of long-term lithium treatment of bipolar disorder on stem cells circulating in peripheral blood.The Staging of Major Mood Disorders: Clinical and Neurobiological Correlates
P2860
Q26738789-E81543F0-0FD8-4854-9817-BD843049BEB1Q26749336-3F0E40F7-BDD9-48C5-8A6C-FAC47A2F585CQ26766633-AEBD1B7D-0DA3-48AD-9909-7A76322E087CQ27023851-5ED850E0-EE14-49B9-8231-FD6316F494BDQ28069988-B9018EA6-8693-4C13-A86F-049B62F740DCQ33578766-6044F323-7BC5-4B82-A8F1-E77B7441B846Q34080310-DA9AF51F-6D05-4909-ABEB-45AD1C795B57Q34649372-403D9BE5-A203-4A3B-8C31-46ACA118F237Q35323821-17875F09-34B6-4FD9-BF53-82D628C9453CQ35701966-6DDB1010-B29A-4859-8B9E-78D38667FB21Q35921070-7DA5144D-558D-4E11-9589-744081B16581Q35964180-B3E710E9-6144-49EB-999F-BC288F13B74AQ36105891-12474ABA-3272-483E-850E-D1E7536FC7CFQ36835108-B507211C-F98E-4DAB-840C-78AF2D5424E2Q37687089-461891E3-5EDF-44B8-A5CB-6C7461AD4ACFQ37705451-A738B33E-71AE-456A-BCA9-7C7B35BBA86BQ38125218-4F412B6A-0859-435B-A258-1113F0772A61Q38535579-A7CEDA77-ADF5-4E62-8A3F-93FDFE4B491CQ38803583-9A69C2EA-D184-40C6-8717-3E0EA7A0F81EQ38836348-6BA7F348-1158-4906-8DBF-FD37C90F8838Q38995726-8C6B576C-99B4-4E92-B9FA-656709A86209Q39264714-48ADA666-89BB-49AA-99C0-3B565C06B16BQ42614417-51E775C0-6652-4DAD-9AB7-835FB3397352Q42669877-7185526D-3F32-4220-9BEE-84D08C52C6ECQ46280363-6C0A1876-BDA1-45DD-AFE7-84CA131A5D16Q47564957-A60E7BCD-FAD3-4713-8BF0-728042D6904DQ47893968-EFF8B87E-4EA4-4928-AAB7-110156F82163Q48199920-AFD65FA1-BDE8-4B0B-BE8B-95AFE2C0EECFQ51840395-6D269365-D750-4F9E-AA40-B951B4E02A41Q53123793-FE3C54E6-313B-47C1-A4F2-3F14712C6FC2Q58734855-2EB19D5F-B2E4-42D7-8E6E-68363BBD1E49
P2860
Mediators of allostasis and systemic toxicity in bipolar disorder.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Mediators of allostasis and systemic toxicity in bipolar disorder.
@en
Mediators of allostasis and systemic toxicity in bipolar disorder.
@nl
type
label
Mediators of allostasis and systemic toxicity in bipolar disorder.
@en
Mediators of allostasis and systemic toxicity in bipolar disorder.
@nl
prefLabel
Mediators of allostasis and systemic toxicity in bipolar disorder.
@en
Mediators of allostasis and systemic toxicity in bipolar disorder.
@nl
P50
P1476
Mediators of allostasis and systemic toxicity in bipolar disorder.
@en
P2093
Pedro V Magalhães
P356
10.1016/J.PHYSBEH.2011.10.029
P407
P577
2011-11-03T00:00:00Z